WallStreetZenWallStreetZen

NASDAQ: VCNX
Vaccinex Inc Stock

$6.58-0.27 (-3.94%)
Updated Jul 12, 2024
VCNX Price
$6.58
Fair Value Price
N/A
Market Cap
$10.42M
52 Week Low
$4.43
52 Week High
$68.46
P/E
-0.24x
P/B
3.92x
P/S
79.31x
PEG
N/A
Dividend Yield
N/A
Revenue
$124.00k
Earnings
-$19.19M
Gross Margin
100%
Operating Margin
-15,472.58%
Profit Margin
-15,472.6%
Debt to Equity
1.78
Operating Cash Flow
-$17M
Beta
0.41
Next Earnings
Aug 12, 2024
Ex-Dividend
N/A
Next Dividend
N/A

VCNX Overview

Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab, a humanized monoclonal antibody that completed and planned Phase 1b/2 clinical trials for the treatment of non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), Huntington's disease, Alzheimer's disease, osteosarcoma, and melanoma. The company is also developing VX5, a human antibody to CXCL13 that is in preclinical development for the treatment of MS and for other autoimmune disorders. Vaccinex, Inc. was incorporated in 2001 and is headquartered in Rochester, New York.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how VCNX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

VCNX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
VCNX is good value based on its book value relative to its share price (3.92x), compared to the US Biotechnology industry average (6.45x)
P/B vs Industry Valuation
VCNX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more VCNX due diligence checks available for Premium users.

Be the first to know about important VCNX news, forecast changes, insider trades & much more!

VCNX News

Valuation

VCNX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.24x
Industry
-12.81x
Market
32.2x

VCNX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.92x
Industry
6.45x
VCNX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

VCNX's financial health

Profit margin

Revenue
$104.0k
Net Income
-$3.9M
Profit Margin
-3,747.1%
VCNX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
VCNX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$7.4M
Liabilities
$4.7M
Debt to equity
1.78
VCNX's short-term assets ($7.15M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
VCNX's short-term assets ($7.15M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
VCNX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
VCNX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.6M
Investing
$0.0
Financing
$6.1M
VCNX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

VCNX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
VCNX$10.42M-4.01%-0.24x3.92x
TCRT$10.41M-1.52%-0.35x2.17x
PSTV$10.38M-1.09%-0.60x-2.15x
TRAW$10.07M+14.70%-0.46x1.67x
MBRX$10.06M+10.13%-0.33x0.47x

Vaccinex Stock FAQ

What is Vaccinex's quote symbol?

(NASDAQ: VCNX) Vaccinex trades on the NASDAQ under the ticker symbol VCNX. Vaccinex stock quotes can also be displayed as NASDAQ: VCNX.

If you're new to stock investing, here's how to buy Vaccinex stock.

What is the 52 week high and low for Vaccinex (NASDAQ: VCNX)?

(NASDAQ: VCNX) Vaccinex's 52-week high was $68.46, and its 52-week low was $4.43. It is currently -90.4% from its 52-week high and 48.35% from its 52-week low.

How much is Vaccinex stock worth today?

(NASDAQ: VCNX) Vaccinex currently has 1,584,300 outstanding shares. With Vaccinex stock trading at $6.58 per share, the total value of Vaccinex stock (market capitalization) is $10.42M.

Vaccinex stock was originally listed at a price of $2,389.80 in Aug 9, 2018. If you had invested in Vaccinex stock at $2,389.80, your return over the last 5 years would have been -99.72%, for an annualized return of -69.25% (not including any dividends or dividend reinvestments).

How much is Vaccinex's stock price per share?

(NASDAQ: VCNX) Vaccinex stock price per share is $6.58 today (as of Jul 12, 2024).

What is Vaccinex's Market Cap?

(NASDAQ: VCNX) Vaccinex's market cap is $10.42M, as of Jul 15, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Vaccinex's market cap is calculated by multiplying VCNX's current stock price of $6.58 by VCNX's total outstanding shares of 1,584,300.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.